相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
H. Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The significance of Treg cells in defective tumor immunity
Agata Kosmaczewska et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions
Mojgan Ahmadzadeh et al.
BLOOD (2008)
FOXP3+ Tregs and B7-HI+/PD-I+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients:: Implication for immunotherapy
Hazem Ghebeh et al.
BMC CANCER (2008)
Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma
T. Yoshioka et al.
BRITISH JOURNAL OF CANCER (2008)
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells
Sylvain Ladoire et al.
CLINICAL CANCER RESEARCH (2008)
Expression of BRCAI protein in breast cancer and its prognostic significance
Emad A. Rakha et al.
HUMAN PATHOLOGY (2008)
Foxp3 expression in human cancer cells
Vaios Karanikas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
Sandra D. Bohling et al.
MODERN PATHOLOGY (2008)
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
Andrew R. Green et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer
Sebastian Hinz et al.
CANCER RESEARCH (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2006)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma
Gerhard G. Grabenbauer et al.
CLINICAL CANCER RESEARCH (2006)
Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome
Marisa Dolled-Filhart et al.
CANCER RESEARCH (2006)
Different patterns of inflammation and prognosis in invasive carcinoma of the breast
AHS Lee et al.
HISTOPATHOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Tumor-infiltrating T lymphocytes: friends or foes?
P Yu et al.
LABORATORY INVESTIGATION (2006)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
C Badoual et al.
CLINICAL CANCER RESEARCH (2006)
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
D Wolf et al.
CLINICAL CANCER RESEARCH (2005)
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
DM Abd El-Rehim et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
G Roncador et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
JD Fontenot et al.
IMMUNITY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Regulating the immune system: the induction of regulatory T cells in the periphery
JH Buckner et al.
ARTHRITIS RESEARCH & THERAPY (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Foxp3 and natural regulatory T cells: Key to a cell lineage?
F Ramsdell
IMMUNITY (2003)
Molecular classification of breast carcinomas using tissue microarrays
G Callagy et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Depletion of CD4+CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes
H Tanaka et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood
D Dieckmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Regulatory T cells: Key controllers of immunologic self-tolerance
S Sakaguchi
CELL (2000)
分享论文
